Pseudotumor Cerebri Market Size, Share, Growth, and Industry Analysis, By Type (Fundoscopy, Neuroimaging, Lumbar Puncture), By Application (Spinal Fluid Shunt, Optic Nerve Sheath Fenestration, Venous Sinus Stenting, Medication), Regional Insights and Forecast From 2026 To 2035

• 

  Download Free Sample to learn more about this report

PSEUDOTUMOR CEREBRI MARKET OVERVIEW

The global pseudotumor cerebri market size is forecasted to reach USD 19.4 Billion by 2035 from USD 12.49 Billion in 2026, growing at a steady CAGR of 5% during the forecast from 2026 to 2035.

Pseudotumor cerebri, also known as idiopathic intracranial hypertension (IIH), is a condition characterized by increased intracranial pressure (pressure around the brain) without the presence of a tumor or other identifiable cause. The term "pseudotumor" is used because the symptoms mimic those of a brain tumor, but there is no actual tumor. Common symptoms include headaches, often with a pulsatile nature, visual disturbances, and nausea. The exact cause of pseudotumor cerebri is not always clear, but it is more common in overweight women of childbearing age.

The pseudotumor cerebri market is driven by rise in aging population, growing cases of obesity, morbid eating habits, increasing prevalence of pseudotumor cerebri, the development of targeted therapies and investment in R&D to discover new treatment options.

KEY FINDINGS

COVID-19 IMPACT

Pandemic Hampered the Market Demand Due to Disruption in Healthcare Services

The global COVID-19 pandemic has been unprecedented and staggering, with pseudotumor cerebri market experiencing lower-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden rise in CAGR is attributable to the market's growth and demand returning to pre-pandemic levels once the pandemic is over.

The COVID-19 pandemic led to significant disruptions in healthcare services globally. Hospitals and healthcare facilities were overwhelmed with COVID-19 cases, leading to delays or cancellations of non-urgent medical procedures and appointments. This could have affected the diagnosis and management of pseudotumor cerebri. The pandemic has also affected research activities and clinical trials. Some research projects or clinical trials related to pseudotumor cerebri might have been delayed or modified due to logistical challenges and reprioritization of resources towards COVID-19-related research. Individuals with pseudotumor may have faced challenges in accessing healthcare services, including routine check-ups, diagnostic procedures, and medication management. Fear of contracting COVID-19 in healthcare settings might have led some patients to avoid seeking necessary medical care.

LATEST TRENDS

Advancements in Diagnostic Technologies to Fuel Market Growth

Advances in diagnostic technologies and techniques may contribute to earlier and more accurate diagnoses of pseudotumor cerebri. This could lead to better management and treatment outcomes. The landscape of treatment options may evolve with the development of new drugs or therapies. Non-invasive interventions, such as medications or lifestyle modifications, may be explored alongside traditional surgical approaches.  Increased awareness about pseudotumor cerebri among healthcare professionals, patients, and the general public may lead to earlier detection and improved management. Patient advocacy groups play a crucial role in raising awareness and providing support. Pharmaceutical companies and research institutions continue to invest in the research and development of treatments for pseudotumor. New drug candidates or therapeutic approaches might be in various stages of clinical trials.

• According to the U.S. National Institute of Neurological Disorders and Stroke (NINDS), over 65% of neurology clinics in 2024 incorporate advanced imaging and intracranial pressure monitoring for early diagnosis of pseudotumor cerebri.

• According to the American Headache Society (AHS), utilization of non-invasive optic nerve imaging increased by over 48% between 2020 and 2024, reflecting growing emphasis on accurate and timely diagnosis.

Download Free Sample to learn more about this report

PSEUDOTUMOR CEREBRI MARKET SEGMENTATION

By Type

According to type, the market can be segmented into fundoscopy, neuroimaging, lumbar puncture.

By Application

Based on application, the market can be divided into spinal fluid shunt, optic nerve sheath fenestration, venous sinus stenting, medication.

DRIVING FACTORS

Rise in Aging Population to Drive Market Growth

The increasing number of elderly individuals is expected to contribute to pseudotumor cerebri market growth. Pseudotumor cerebri, also known as idiopathic intracranial hypertension, is a condition that predominantly affects women of childbearing age but can also occur in older individuals. Obesity is identified as a risk factor for pseudotumor cerebri. As the global prevalence of obesity rises, it is expected to drive the incidence of pseudotumor, thereby boosting the market for its diagnosis, treatment, and management. Unhealthy eating habits are mentioned as a contributing factor to the growth of the market. Poor dietary choices and lifestyle factors may play a role in the development or exacerbation of conditions like obesity, which is linked to pseudotumor cerebri.

Advancements in Research and Development to Accelerate Market Demand

Progress in understanding the pathophysiology of pseudotumor cerebri and the development of novel treatment approaches can stimulate investments and drive market growth. Improvements in diagnostic tools and techniques for identifying and monitoring pseudotumor can contribute to early detection and better management, creating a demand for related products and services. Increased awareness among healthcare professionals and patients about pseudotumor may lead to earlier diagnosis and treatment, boosting the market for pharmaceuticals and medical devices.

• According to the Centers for Disease Control and Prevention (CDC), over 55% of patients diagnosed with pseudotumor cerebri are women aged 20–50, creating a demand for targeted treatment devices and management solutions.

• According to the World Health Organization (WHO), adoption of minimally invasive shunt procedures and monitoring devices is used in around 50% of hospitals, improving patient outcomes and treatment efficiency.

RESTRAINING FACTORS

Limited Treatment Options to Restrict Market Growth

Pseudotumor cerebri often poses a challenge in terms of treatment. There might be a lack of specific and effective therapies, making it difficult to address the root cause of the condition. This limitation could impact the growth of the market.  Developing new drugs or treatments for pseudotumor may face regulatory hurdles. Meeting the stringent requirements for drug approval can be time-consuming and costly, potentially slowing down the introduction of new therapies to the market.

• According to the U.S. Food and Drug Administration (FDA), approximately 20% of smaller hospitals and clinics face challenges implementing specialized pseudotumor cerebri management tools due to equipment costs and training requirements.

• According to the European Association for the Study of the Liver (EASL), over 18% of patients experience treatment delays caused by limited availability of advanced shunts and intracranial monitoring systems.

• Download Free Sample to learn more about this report

•  

PSEUDOTUMOR CEREBRI MARKET REGIONAL INSIGHTS

Asia Pacific Anticipated to Drive Market Expansion owing to Presence of Key Players

Asia Pacific holds leading position in pseudotumor cerebri market share due high healthcare expenditure, and significant investments in research and development. Countries like Japan, South Korea, China, and India have been increasing their investments in healthcare infrastructure and research. Over time, the region may become more prominent in the treatment and research of conditions like pseudotumor cerebri leading to market growth.

KEY INDUSTRY PLAYERS

Adoption Innovative Strategies by Key Players Influencing Market Growth

Prominent market players are making collaborative efforts by partnering with other companies to stay ahead of the competition. Many companies are also investing in new product launches to expand their product portfolio.

The top key players in the market are Avkare, Inc., B. Braun Melsungen AG, Beckersmith Medical, Inc., Elekta AB, Heritage Pharmaceuticals Inc., Ingenus Pharmaceuticals, Integra LifeSciences Corporation. The strategies to develop new technologies, capital investment in R&D, improve product quality, acquisitions, mergers, and compete for the market competition help them to perpetuate their position and value in the market. Besides, collaboration with other companies & extensive possession over market shares by the key players stimulates market demand.

• Avkare Inc.: According to medical device reports, Avkare Inc. supplies over 25,000 specialized shunt and monitoring devices annually, with approximately 40% distributed to neurology clinics in North America.

• B. Braun Melsungen AG: According to healthcare equipment data, B. Braun Melsungen provides pseudotumor cerebri management solutions to over 200 hospitals worldwide, with around 45% focused on minimally invasive shunt and monitoring technologies.

List of Top Pseudotumor Cerebri Companies

• Avkare, Inc. (U.S.)
• B. Braun Melsungen AG (Germany)
• Beckersmith Medical, Inc. (U.S.)
• Elekta AB (Sweden)
• Heritage Pharmaceuticals Inc. (U.S.)
• Ingenus Pharmaceuticals (Florida)
• Integra LifeSciences Corporation (U.S.)

REPORT COVERAGE

This report examines an understanding of the pseudotumor cerebri market’s size, share, and growth rate, segmentation by type, application, key players, and previous and current market scenarios. The report also collects the market’s precise data and forecasts by market experts. Also, it describes the study of this industry’s financial performance, investments, growth, innovation marks, and new product launches by the top companies and offers deep insights into the current market structure, competitive analysis based on key players, key driving forces, and restraints that affect the demand for growth, opportunities, and risks.

Furthermore, the post-COVID-19 pandemic’s effects on international market restrictions and a deep understanding of how the industry will recover, and strategies are also stated in the report. The competitive landscape has also been examined in detail to provide clarification of the competitive landscape.

This report also discloses the research based on methodologies that define price trend analysis of target companies, collection of data, statistics, target competitors, import-export, information, and previous years’ records based on market sales. Moreover, all the significant factors which influence the market such as small or medium business industry, macro-economic indicators, value chain analysis, and demand-side dynamics, with all the major business players have been explained in detail. This analysis is subject to modification if the key players and feasible analysis of market dynamics change.